Key result
Pulmonary vein isolation using the second-generation cryoballoon in patients with persistent atrial fibrillation resulted in 63.3% freedom from atrial arrhythmias at a median 33 months follow-up.
Why the study?
Does pulmonary vein isolation using the second-generation cryoballoon prevent arrhythmia recurrence in patients with persistent atrial fibrillation?
Cohort (n=281)
No
Does pulmonary vein isolation using the second-generation cryoballoon prevent arrhythmia recurrence in patients with persistent atrial fibrillation?
Pulmonary vein isolation using the second-generation cryoballoon for persistent AF provides a 63.3% mid-term success rate, highlighting the importance of patient selection (e.g., left atrial size) and procedural experience.
Answers are grounded in this paper and cite their sources.
Cryoballoon PVI may yield mid-term success in persistent AF; leaves open optimal selection and randomized confirmation before practice change.
INTRODUCTION: We analyzed the procedural experience and clinical outcome after pulmonary vein isolation (PVI) in patients with persistent atrial fibrillation (AF) gained over 5 years using the second-generation cryoballoon (CB-Adv). METHODS AND RESULTS: For this retrospective study, we enrolled 281 patients undergoing PVI at our institution between 2012 and 2016. The analyzed period was divided into 5 calendar years. Follow-up data, including Holter electrocardiography recordings, were collected during outpatient clinic visits. The impact of several variables on outcome was evaluated by means of univariate and multivariate analyses and Cox proportional hazards regression models. The median procedure and fluoroscopy times over the years were 90 (72 of 114) and 15 (11 of 21) minutes, respectively. A continuous decline in complication rates and fluoroscopy and procedure times was observed in each subsequent year. During mid-term follow-up (33 [25 of 48] months), 178 (63.3%) patients were AF, atrial flutter, or atrial tachycardia free. Multivariate analysis revealed left atrial area (hazard ratio [HR] = 1.05; P < 0.001), female sex (HR = 2.53; P < 0.001), and common ostium (HR = 1.93; P < 0.001) as significant predictors of outcome. The overall 1-year success rate was 76.2%. A gradual decrease in the 1-year success rate (from 90.5% in 2012 to 67.9% in 2016) was mainly related to a steady increase of left atrial area in the entire cohort with successive years of the study. CONCLUSIONS: PVI using CB-Adv in patients with persistent AF is accompanied by a learning curve and facilitates a satisfactory outcome, followed by the proper selection of patients.
No takes yet. Share an insight, caveat, or question.
Akkaya et al. (2018) conducted a cohort in persistent atrial fibrillation (n=281). Pulmonary vein isolation using the second-generation cryoballoon (CB-Adv) was evaluated on Freedom from AF, atrial flutter, or atrial tachycardia. Pulmonary vein isolation using the second-generation cryoballoon in patients with persistent atrial fibrillation resulted in 63.3% freedom from atrial arrhythmias at a median 33 months follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: